HopeStage
Back to all studies
CompletedNCT04080427

Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study

It focuses on PTSD and currently lists study information in the United States.

PTSDDrugFrom 18 Years to 60 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
Detroit, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateStarted: April 15, 2021
Recruitment status
Completed
Enrollment listed in the registry
102
Sponsor
Wayne State University
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT04080427
Official title
Effects of THC on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Detroit

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wayne State University, a university.

Did this study involve medication?

Yes. The study involved medication, including Placebo capsule and Dronabinol 7.5 milligram oral capsule.

Who was this study for?

Listed age limits: 18 years to 60 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me